In Vivo Screening Data Summary

NCI In Vivo Screening Data

Ependymoblastoma (intracerebral) in C57BL/6 mice

NSC 119875
CAS 15663-27-1
Cisplatin; Plantinol AQ; Cis-DDP

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX005 (ip) median survival time saline 0.25 mg/kg/injection 116.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 0.25 mg/kg/injection 122.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 0.5 mg/kg/injection 110.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 0.5 mg/kg/injection 112.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 1.0 mg/kg/injection 138.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 1.0 mg/kg/injection 131.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 2.0 mg/kg/injection 169.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 2.0 mg/kg/injection 141.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 4.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 4.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 8.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time saline 8.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 04/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 0.4 mg/kg/injection 113.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 0.4 mg/kg/injection 96.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 0.8 mg/kg/injection 122.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 0.8 mg/kg/injection 121.0 Antitumor endpoint evaluated on day 60; 08/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 1.6 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 1.6 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 3.2 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 05/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 3.2 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 6.4 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5)
Q01DX005 (ip) median survival time sodium bicarbonate 6.4 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5)